Related Experiment Video
Updated: Oct 5, 2025

08:35
Complete Thymectomy in Adult Rats with Non-invasive Endotracheal Intubation
Published on: December 29, 2014
16.9K
Thymectomy for myasthenia gravis: A pathological analysis
Shweta Bansod1, Pradeep Vaideeswar2, Sangeeta Ravat3
1Department of Pathology, Seth GS Medical College, Mumbai, Maharashtra, India.
Indian Journal of Pathology & Microbiology
|January 25, 2022
Summary
This study analyzed thymuses from myasthenia gravis patients, finding thymomas in over half of cases. Thymic pathology is common in myasthenia gravis, with tumors often showing a cortical phenotype.
Area of Science:
- Neurology
- Immunology
- Pathology
Background:
- Myasthenia gravis (MG) is an autoimmune disorder affecting neuromuscular junctions.
- It is characterized by antibodies against acetylcholine receptors, leading to muscle weakness.
- Thymic abnormalities are frequently associated with myasthenia gravis.
Purpose of the Study:
- To investigate the range of pathological findings in thymuses from patients with myasthenia gravis.
- To correlate thymic pathology with clinical presentation and treatment outcomes.
Main Methods:
- A retrospective analysis of 68 thymectomy specimens from myasthenia gravis patients over 10 years.
- Histopathological examination of excised thymuses.
Main Results:
- The study included 47 males and 21 females with a mean age of 41 years.
- Thymic abnormalities were prevalent: 13.2% normal, 25% atrophic, 8.8% follicular hyperplasia, and 53% thymomas.
- Thymomas were the most frequent finding, predominantly of the cortical phenotype.
Conclusions:
- Histological examination of thymectomies in myasthenia gravis patients reveals a diverse spectrum of pathology.
- Thymomas are a significant finding, often exhibiting cortical features.
- Understanding thymic pathology is crucial for managing myasthenia gravis.
Related Concept Videos
Myasthenia Gravis: Overview and Treatment
2.1K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.1K
Myasthenia Gravis: Diagnostic Tests
1.5K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.5K

